Virtual Reality Dietary Counseling for Fatty Liver Disease
Trial Summary
What is the purpose of this trial?
Metabolic-dysfunction associated steatotic liver disease, often referred to as "fatty liver disease", is a leading cause of liver failure. Dietary weight loss is a cornerstone of treating fatty liver disease, but access to traditional in-person nutritional education is often limited by cost, availability, and transportation. Immersive virtual reality (iVR) has the potential to not only overcome these barriers, but also provide an interactive learning experience, such as measuring and preparing foods. Therefore, the investigators have created and validated an iVR dietician program known as the Immersive Virtual Alimentation and Nutrition (IVAN) using evidence-informed practices from the Academy of Nutrition and Dietetics. The goal of this project is to translate the IVAN program from human and patient research to practice and community research. The investigators plan to accomplish this by performing a randomized clinical trial evaluating the effect of the IVAN program in combination with synchronous audio/video dietary counseling on self-reported dietary intake and weight compared to in-person counseling. Concurrently, the investigators will provide a survey assessing implementation outcomes to both groups as well as the dietician at each study visit, and crossover the intervention at study completion so all participants assess the IVAN program. Additionally, the investigators will have clinic health care providers experience the IVAN program and assess implementation outcomes.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Immersive Virtual Alimentation and Nutrition (IVAN) for Fatty Liver Disease?
Research shows that virtual reality (VR) technologies can help improve healthy eating and physical activity, which are important for managing conditions like obesity and diabetes. These findings suggest that VR could also be effective in promoting lifestyle changes needed for managing fatty liver disease.12345
Is virtual reality dietary counseling safe for humans?
How is the treatment IVAN unique for managing fatty liver disease?
IVAN uses virtual reality (VR) technology to provide an immersive and interactive environment for dietary counseling, which is different from traditional treatments that may not engage patients as effectively. This approach can help patients adopt healthier eating habits by simulating real-life food choices and providing personalized feedback, making it a novel way to manage dietary aspects of fatty liver disease.23468
Research Team
Justin Tondt, MD
Principal Investigator
Penn State
Eligibility Criteria
This trial is for adults over 18 with metabolic-dysfunction associated steatotic liver disease (fatty liver) confirmed by a Fibroscan. Participants must own a smartphone to access the virtual reality program.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either in-person or virtual reality dietary weight loss counseling for 12 weeks
Crossover
Participants crossover to assess the alternative intervention (IVAN program or in-person counseling)
Follow-up
Participants are monitored for changes in dietary intake and body weight after treatment
Treatment Details
Interventions
- Immersive Virtual Alimentation and Nutrition (IVAN)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Milton S. Hershey Medical Center
Lead Sponsor